
Company Description
LINDIS Biotech is to develop ektomun, an innovative immunotherapeutic for the treatment of small cell lung cancer, melanoma.
LINDIS Biotech was founded to develop ektomun, an innovative immunotherapeutic for the treatment of small cell lung cancer, melanoma and other neuroectodermal cancers that currently lack sufficient treatment options.
-
Manufacturer:
Science and Engineering -
Company Website:
-
Company E-mail:
-
Company Address:
Am Klopferspitz 19MartinsriedGermany -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits